Two months ago, Guangdong Kaipu Biotechnology Co., Ltd. (hereinafter referred to as Kaipu Bio) was listed on the GEM of the Shenzhen Stock Exchange. Landing in the capital market will inject more resources into scientific research.

"Cervical cancer may become the world's first cancer to be eliminated." Guan Yusheng, deputy general manager of Capt Bio, said with confidence. His self-confidence stems from the self-developed molecular diagnostic technology that can be successfully predicted 8 years before the onset of cervical cancer, which is significantly more efficient than traditional cytology screening, providing patients with adequate prevention and treatment time.

As a leading company in the national in vitro testing industry, Kaipu Bio has been effective in promoting the popularization of new technologies for cervical cancer screening. At present, the screening service population has accumulated about 16 million. At the end of last year, in the 18th China Patent Award, which was hailed as “China Intellectual Property Oscar”, the Kaipu invention patent “Human Papilloma Virus Genotyping Detection Kit and Its Gene Chip Preparation Method” won the Chinese patent. The Gold Award has become the only gold award for patent innovation in the field of in vitro diagnostics.

凯普生物:分子诊断技术可在癌变8年前检测出来

Study cervical cancer "culprits"

“Guangzhou Creation” won the China Invention Patent Gold Award

In the field of HPV (Human Papilloma Virus) detection nucleic acid molecule diagnosis, Capum Bio represents the current global leading level of independent innovation in China.

Guan Yusheng said that unlike other cancers, scientific research has shown that 99% of the main factors causing cervical cancer lesions are due to persistent infection of HPV virus. "It can be said that controlling HPV virus is to control cervical cancer." In order to prevent cervical cancer, Cape Bio began with its "culprit" and carried out more than ten years of special research. “It can be said that no biopharmaceutical company knows more about HPV than we do.”

The breakthrough in cervical cancer detection is from "finding the lesion" to "finding the source." According to Xie Longxu, chief scientist of Kaipu Biotechnology, the population-based screening, HPV virus detection is more suitable for first-line screening in China, which can greatly reduce the rate of missed diagnosis and improve the specificity and accuracy of screening. At the same time, they also carried out HPV typing tests, which can accurately determine whether they are persistent infections or continuous infections, classify high-risk groups and low-risk groups, and predict the risk trends of disease development. “The earliest can even be cancerous. It was detected 8 years ago and it has given patients sufficient treatment time."

Hanging Fire Extinguisher

Hanging Fire Extinguisher,Carbon Dioxide Fire Extinguisher,Fire Extinguisher Equipment,Automobile Automatic Fire Extinguisher

DONGGUAN TENYU TECH.INC , https://www.tenyutech.com